Cooper Companies (NASDAQ:COO) Issues Quarterly Earnings Results, Hits Expectations

Cooper Companies (NASDAQ:COO) announced its earnings results on Thursday. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92, Zacks reports. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Cooper Companies updated its FY 2025 guidance to 3.940-4.020 EPS.

Cooper Companies Price Performance

COO stock traded down $0.35 during trading on Thursday, hitting $90.98. The stock had a trading volume of 2,857,025 shares, compared to its average volume of 1,546,712. The company’s 50-day moving average price is $92.56 and its two-hundred day moving average price is $99.51. Cooper Companies has a twelve month low of $84.76 and a twelve month high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The stock has a market capitalization of $18.16 billion, a P/E ratio of 46.66, a PEG ratio of 2.25 and a beta of 1.02.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Wells Fargo & Company upped their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Finally, Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.22.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.